WHO just approved a major shift in HIV prevention — and it comes as the world stalls on progress.
By Aniket Chakraborty
July 16, 2025
Arrow
HEALTH & WELLNESS
Arrow
Meet
lenacapavir
: a twice-a-year injection offering near-total protection against HIV.
2
Arrow
The FDA greenlit it recently — and now WHO is urging global rollout in high-risk regions.
3
Arrow
It’s a breakthrough for those struggling with daily pills, stigma, or health access gaps.
4
Arrow
The science is solid: lenacapavir disrupts HIV at multiple stages using capsid inhibition.
5
Arrow
But access won’t be easy — Trump’s U.S. aid cuts have gutted HIV funding globally.
6
Arrow
PrEP use has already collapsed in countries like Nigeria since the cuts began.
7
Arrow
WHO also recommends rapid-test models and pharmacy-based delivery to simplify care.
8
Arrow
Gilead will supply the drug at cost through the Global Fund — but only in select regions.
9
As vaccine hopes stall, lenacapavir may be our best shot — if the world can afford it.
10